REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Poltiss Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Navigational, Measuring, Electromedical, and Control Instruments Manufacturing | Machinery, Equipment, and Supplies Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | Engineering Services | Scientific Research and Development Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Professional, Scientific, and Technical Services
Full name: Poltiss Sp. z o.o. Profile Updated: December 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

POLTISS provides PhotoBioCure, a polymeric materials based platform technology that turns sticky liquids into a flexible solids under UV radiation and helps in tissue generation.

Headquarters
Ul. Al. Wojska Polskiego 150/1
Szczecin; Zachodniopomorskie; Postal Code: 71-324

Contact Details: Purchase the Poltiss Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Poltiss Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Poltiss Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Poltiss Sp. z o.o. report to view the information.
Incorporation Date:
September 10, 2015
Key Executives
Purchase this report to view the information.
W Organie Prezes Zarzadu Reprezentujacym
Ownership Details
Purchase this report to view the information.
44.39%
Purchase this report to view the information.
25.23%
Purchase this report to view the information.
23.83%
Company Performance
Financial values in the chart are available after Poltiss Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total operating revenue
-75.57%▼
Operating Profit/Loss (EBIT)
86.17%▲
EBITDA
94.43%▲
Net Profit/Loss for the Period
78.19%▲
Total Assets
-15.82%▼
Total Equity
-31.54%▼
Return on Equity (ROE)
-120.63%▼
Quick Ratio
-0.03%▼
Cash Ratio
0.04%▲

Similar companies

Wojskowy Instytut Medyczny - Panstwowy Instytut Badawczy
 
"Novo Nordisk Pharma" Sp. z o.o.
Selvita S.A.
 
Polpharma Biologics S.A.
Instytut Lacznosci - Panstwowy Instytut Badawczy
 
Kcr S.A.
Vitagenum Sp. z o.o.
 
Biolam Sp. z o.o.
Science-Bridge Sp. z o.o.
 
Xenogp Sp. z o.o.
Vaxican Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo